The FDA Could Help Address Financial Toxicity During the Approval Process
Sep 21, 2019 - Cancer is among the costliest medical conditions to treat in the United States, causing many patients to experience “financial toxicity.” This term is often used to describe how out-of-pocket costs can cause financial distress to patients. One ...Leggi tutto